ArticleFrontiers in pharmacology2020

Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity.

Alan S Premasiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.